|
NFXL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.090200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.478030E-01 |
| Normal-vs-Stage2 |
4.029200E-01 |
| Normal-vs-Stage3 |
3.270400E-02 |
| Normal-vs-Stage4 |
9.592800E-01 |
| Stage1-vs-Stage2 |
9.786000E-01 |
| Stage1-vs-Stage3 |
2.811200E-01 |
| Stage1-vs-Stage4 |
4.941400E-01 |
| Stage2-vs-Stage3 |
4.519200E-01 |
| Stage2-vs-Stage4 |
5.662200E-01 |
| Stage3-vs-Stage4 |
1.544220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.852100E-02 |
| Normal-vs-AfricanAmerican |
6.997600E-01 |
| Normal-vs-Asian |
9.185400E-01 |
| Caucasian-vs-AfricanAmerican |
2.075000E-01 |
| Caucasian-vs-Asian |
5.781800E-01 |
| AfricanAmerican-vs-Asian |
8.519800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.194800E-01 |
| Normal-vs-Female |
3.313800E-01 |
| Male-vs-Female |
9.903800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.362800E-01 |
| Normal-vs-Extreme_Weight |
2.638200E-02 |
| Normal-vs-Obese |
6.113000E-01 |
| Normal-vs-Extreme_Obese |
2.079400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.856000E-01 |
| Normal_Weight-vs-Obese |
4.773800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.470400E-01 |
| Extreme_Weight-vs-Obese |
8.694400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.943200E-01 |
| Obese-vs-Extreme_Obese |
4.869600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.423200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.339800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.477600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.995300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.001000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.142000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.553930E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.703990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.215990E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.594400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.416600E-01 |
| Normal-VS-Type2 PRCC |
1.210010E-02 |
| Normal-VS-KIRP CIMP |
5.301800E-01 |
| Normal-VS-Unclassified PRCC |
7.320000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.786400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.927800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.753000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.542800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.552200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.637600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.033600E-04 |
| Normal-vs-N1 |
3.102600E-01 |
| Normal-vs-N2 |
7.737900E-02 |
| N0-vs-N1 |
3.245500E-02 |
| N0-vs-N2 |
6.547600E-01 |
| N1-vs-N2 |
2.537400E-01 |
|
|
